STOCK TITAN

SHF Holdings share count jumps to 132M after conversions

Series B conversions lifted SHFS common shares outstanding to 132,248,520, while the proposed Opifex combination remains subject to approvals and closing conditions.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

SHF Holdings, Inc. (SHFS) reported third-quarter 2026 revenue of $1.95 million, up 6.5% year over year; loan program income rose 70.2% to approximately $869,000, and operating loss narrowed 17.7% to approximately $1.00 million. Net loss was approximately $979,000, compared with net income of $180,000 a year earlier. Cash was $4.40 million as of September 30, 2026, and net cash used in operating activities was $4.05 million for the nine months ended then. Its unaudited statements include a going-concern disclosure, and management said its plans have not alleviated substantial doubt.

From October 22 through November 6, 2026, holders converted 19,529 Series B preferred shares into 131,219,818 common shares; common shares outstanding increased from 1,028,702 on September 30 to 132,248,520 on November 6. Another 7,605 preferred shares remained convertible into a maximum of approximately 62.9 million common shares. An October 23 nonbinding term sheet contemplates Opifex holders owning approximately 85% of the combined company and existing SHF stakeholders approximately 15%, adjustable from 12.5% to 17.5%. Nasdaq granted until April 19, 2027, to regain compliance with the $1 minimum bid price requirement.

3 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

3 major · 4 points

How the balance works

Positive

  • Moderate pointRevenue rose 6.5% to $1.95 million in Q3 2026.
  • Moderate pointLoan program income rose 70.2% to approximately $869,000.
  • Moderate pointOperating loss narrowed 17.7% to approximately $1.00 million.

Negative

  • Major pointGoing-concern disclosure: substantial doubt remains; nine-month operating cash use was $4.05 million.
  • Major pointSeries B conversions: common shares outstanding reached 132,248,520 by November 6.
  • Major pointQ3 net loss was $979,000, versus $180,000 net income in Q3 2025.
  • Minor pointNasdaq extended the $1 minimum bid-price compliance period through April 19, 2027.

Filing Explained

The letter says SHFS had eight consecutive closes below ten cents, and continued declines could bring Nasdaq suspension before April 19, 2027.

Alongside third-quarter results, the CEO’s letter says SHF does not intend to draw on its equity line while the nonbinding Opifex term sheet remains in effect, leaving this financing source unused under its stated plan.

SHF says it raised $1.1 million under the line during the first nine months of 2026; each draw must direct 25% of proceeds to redeem Series B preferred stock, and draw availability is limited when the stock trades below $1.00.

The letter says the September 30, 2026 reverse split triggered a Series B conversion-price reset from $18.6336 to $0.1210 on October 22, 2026, while the warrant exercise price remained $18.6336. SHF reports stockholders’ equity of $5.2 million against Nasdaq’s $2.5 million minimum, but says this does not resolve the separate bid-price deficiency; despite the compliance period through April 19, 2027, ten consecutive closing bids at or below $0.10 would trigger a delisting determination, and SHF had closed below that level for eight consecutive business days, with suspension and delisting possible before the deadline if the pattern continued.

For the Abaca litigation, the damages trial was held August 10–11, 2026 and no ruling had issued; SHF estimates a possible loss of $0 to $7.8 million plus interest, says an adverse ruling near the upper end would exceed available liquidity, and reports that the $3.0 million deposited with the court is unavailable for operations.

Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Third-quarter revenue $1.95 million Three months ended September 30, 2026; increased 6.5% year over year
Loan program income Approximately $869,000 Q3 2026; increased 70.2% year over year
Operating loss Approximately $1.00 million Q3 2026; narrowed 17.7% year over year
Net loss Approximately $979,000 Q3 2026; compared with net income of $180,000 in Q3 2025
Cash and cash equivalents $4.40 million As of September 30, 2026
Common shares outstanding 132,248,520 shares As of November 6, 2026; increased from 1,028,702 shares on September 30, 2026
Remaining Series B preferred shares 7,605 shares; convertible into a maximum of approximately 62.9 million common shares As of November 6, 2026
Proposed combined-company ownership Approximately 85% for Opifex holders; approximately 15% for existing SHF stakeholders, adjustable from 12.5% to 17.5% Nonbinding term sheet; proposed transaction
going concern financial
"going concern disclosure resulting from recurring operating losses"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
fully diluted financial
"fully diluted shares immediately after closing"
Fully diluted is the total number of a company's shares that would exist if every potential share from stock options, warrants, convertible debt and other claims were converted into common stock — like counting every reserved pizza slice as if everyone who could request one already had it. Investors use the fully diluted share count to see the realistic ownership picture and how those future claims could lower each shareholder’s percentage, earnings per share and implied valuation.
reverse acquisition technical
"expected to be accounted for as a reverse acquisition"
A reverse acquisition is when a private company becomes publicly traded by buying a listed company—often a low-activity “shell”—instead of going through a traditional initial public offering. For investors, it can quickly create tradable shares and access to capital but also reshuffles ownership and can bring limited disclosure or integration risks; think of it as buying an existing storefront to start selling immediately rather than building one from the ground up.
fairness opinion financial
"an independent valuation and fairness opinion"
A fairness opinion is a professional assessment that evaluates whether the terms of a financial deal, such as a merger or acquisition, are fair from a financial point of view. It helps investors and stakeholders understand if the deal is reasonable and balanced, much like an independent expert giving an unbiased judgment on whether a price or agreement is fair. This assurance can increase confidence that the transaction is fair for all parties involved.
minimum bid price requirement regulatory
"regain compliance with the $1 minimum bid price requirement"
A minimum bid price requirement is a rule that a stock must trade above a set price for a specified period to stay listed on an exchange. It matters to investors because falling below that threshold can trigger warnings or removal from the exchange, which can cut liquidity, reduce visibility, and often lead to sharper declines in share value—think of it like a venue’s minimum dress code that, if not met, can bar a performer from the stage.
Revenue $1.95 million increased 6.5% from $1.83 million in Q3 2025
Operating expenses $2.95 million decreased 3.2% from $3.05 million in Q3 2025
Operating loss Approximately $1.00 million narrowed 17.7% from $1.22 million in Q3 2025
Net loss Approximately $979,000 compared with net income of approximately $180,000 in Q3 2025

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How did SHFS perform in the third quarter of 2026?

SHF Holdings reported revenue of $1.95 million, up 6.5%, and loan program income of approximately $869,000, up 70.2%. Operating loss narrowed 17.7% to approximately $1.00 million, while net loss was approximately $979,000 compared with net income of $180,000 in Q3 2025.

How many shares were converted from SHFS Series B preferred stock?

From October 22 through November 6, 2026, holders converted 19,529 Series B preferred shares into 131,219,818 common shares. Common shares outstanding increased from 1,028,702 on September 30, 2026, to 132,248,520 on November 6, 2026. Another 7,605 preferred shares remained convertible into a maximum of approximately 62.9 million common shares.

What ownership split does the proposed SHFS-Opifex transaction contemplate?

The nonbinding term sheet contemplates Opifex security holders owning approximately 85% of the combined company and existing SHF stakeholders approximately 15%. The SHF allocation may be adjusted within a range of 12.5% to 17.5% based on SHF’s valuation at closing, supported by an independent fairness opinion.

What is SHFS's Nasdaq bid-price compliance deadline?

Nasdaq granted SHF until April 19, 2027, to regain compliance. The company said its stock must close at or above $1.00 for at least 10 consecutive business days before then. Nasdaq rules also provide for a delisting determination if the common stock closes at $0.10 or less for 10 consecutive business days.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001854963 0001854963 2026-11-09 2026-11-09 0001854963 SHFS:ClassCommonStock0.0001ParValuePerShareMember 2026-11-09 2026-11-09 0001854963 SHFS:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf230.00PerShareMember 2026-11-09 2026-11-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 9, 2026

 

SHF Holdings, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

(State or other jurisdiction of incorporation)

 

001-40524   86-2409612

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

1526 Cole Blvd., Suite 250

Golden, Colorado 80401

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code (303) 431-3435

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☒ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☒ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading Symbol(s)   Name of Each Exchange on Which Registered
Class A Common Stock, $0.0001 par value per share   SHFS   The Nasdaq Stock Market LLC
Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $230.00 per share   SHFSW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 2.02. Results of Operations and Financial Condition.

 

On November 9, 2026, SHF Holdings, Inc. (“SHF” or the “Company”) issued a press release announcing its financial results for the three months ended September 30, 2026.

 

The information contained in this Item 2.02 and Exhibit 99.1 of this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”) or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing or as otherwise required by applicable law. The furnishing of the information in this Item 2.02 and Exhibit 99.1 of this Current Report on Form 8-K is not intended to, and does not, constitute a representation that such furnishing is required by Regulation FD or that the information contained in this Current Report on Form 8-K constitutes material investor information that is not otherwise publicly available.

 

Item 8.01. Other Events.

 

On November 9, 2026, Terrance Mendez, Chief Executive Officer, Chief Financial Officer and Director of SHF, issued a letter to SHF’s stockholders regarding, among other things the Company’s financial results and the proposed transaction (the “Proposed Transaction”) with Opifex Media Inc. (“Opifex”). A copy of the letter is attached as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated herein by reference.

 

Solicitation Material

 

This communication may be deemed to be solicitation material in connection with the proposals to be submitted to SHF’s stockholders at a meeting of stockholders seeking approval of certain matters in connection with the Proposed Transaction. In connection with the proposals, SHF may file with the SEC a registration statement on Form S-4 (the “Registration Statement”), which will include a proxy statement of SHF and a prospectus (the “Proxy Statement/Prospectus”). After the Registration Statement is declared effective, SHF will mail the definitive Proxy Statement/Prospectus to its stockholders. INVESTORS AND SECURITY HOLDERS OF SHF ARE URGED TO READ THE REGISTRATION STATEMENT, THE PROXY STATEMENT/PROSPECTUS AND ALL OTHER RELEVANT DOCUMENTS FILED WITH THE SEC, AND ANY AMENDMENTS OR SUPPLEMENTS THERETO, CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT SHF, OPIFEX, THE PROPOSED TRANSACTION AND THE PROPOSALS. Investors and security holders may obtain free copies of the Registration Statement, the Proxy Statement/Prospectus and other documents that SHF files with the SEC, when available, at the SEC’s website (www.sec.gov) or from SHF by accessing information included on SHF’s website (ir.shfinancial.org), which is not incorporated by reference herein.

 

Participants in the Solicitation

 

SHF, Opifex and their respective directors and certain of their respective executive officers may be deemed participants in the solicitation of proxies from SHF’s stockholders in connection with the Proposed Transaction. Information about SHF’s directors and executive officers, including their ownership of SHF securities, appears in SHF’s proxy statement for its 2026 annual meeting of stockholders, filed with the SEC on May 8, 2026 (under the captions “Security Ownership of Certain Beneficial Owners and Management” and “Compensation Discussion and Analysis”), and in its Annual Report on Form 10-K filed with the SEC on April 15, 2026. Changes in their holdings since those dates have been or will be reflected in Forms 3, 4, or 5 filed with the SEC. Information about Opifex’s directors and executive officers, and additional information about all participants and a description of their direct and indirect interests, by security holdings or otherwise, will be included in the Proxy Statement/Prospectus and other relevant materials filed with the SEC when they become available. These documents can be obtained free of charge as described above.

 

No Offer or Solicitation

 

This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act.

 

Item 9.01. Financial Statements and Exhibits.

 

Exhibit No.   Description
99.1   Press Release dated November 9, 2026.
99.2   Letter to Stockholders, dated November 9, 2026.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  SHF HOLDINGS, INC.
     
Date: November 9, 2026 By: /s/ Terrance Mendez
    Terrance Mendez
    Chief Executive Officer and Chief Financial Officer

 

 

 

 

Exhibit 99.1

 

Safe Harbor Financial Reports Third Quarter 2026 Financial Results

 

Revenue increases 6.5% to $1.95 million, supported by 70.2% growth in loan program income

 

Average client deposits rise to $112 million, with quarter-end trailing 14-day average deposits reaching $119.3 million

 

Operating loss narrows 17.7% year over year

 

GOLDEN, Colo., Nov. 9, 2026 — SHF Holdings, Inc., doing business as Safe Harbor (the “Company” or “Safe Harbor”) (Nasdaq: SHFS), a fintech platform serving the banking, lending and financial services needs of the regulated cannabis and hemp industries, today reported financial results for the third quarter ended September 30, 2026.

 

Safe Harbor reported third-quarter revenue of $1.95 million, an increase of 6.5% compared with $1.83 million in the prior-year period. Revenue growth was primarily driven by a 70.2% increase in loan program income, reflecting improved revenue-sharing economics under the Company’s amended agreement with Partner Colorado Credit Union that more than offset lower average loan portfolio balances.

 

Average client deposit balances increased 3.8% year over year to $112 million, while the trailing 14-day average deposit balance at quarter-end reached $119.3 million, an increase of 7.4% from the prior-year period. The quarter-end trailing 14-day balance was the Company’s highest since April 2024. The Average account balance increased 5.6% from the prior-year period, reflecting higher deposit balances across the Company’s client relationships.

 

Operating loss in the third quarter narrowed 17.7% year over year to approximately $1 million, reflecting higher revenue, lower compensation expenses and a credit benefit associated with changes in estimated credit losses. These benefits were partially offset by increased professional services and other operating costs.

 

“Our third-quarter results demonstrate the continued value of Safe Harbor’s established financial services platform, with higher revenue, significant growth in loan program income and increased client deposit balances,” said Terry Mendez, Chief Executive Officer of Safe Harbor. “Our enhanced lending economics are contributing to revenue growth, while our deposit performance reflects the strength of the client relationships and specialized banking infrastructure we have built over more than a decade.”

 

“At the same time, we recognize the challenges facing our capital structure and public listing and remain focused on evaluating solutions that preserve the value of our operating business,” Mr. Mendez continued. “Our priorities are maintaining service to our clients and financial institution partners, managing liquidity and pursuing strategic opportunities that may support a more sustainable path forward.”

 

Third Quarter 2026 Financial Highlights

 

  ● Total revenue increased 6.5% to $1.95 million, compared with $1.83 million in the third quarter of 2025.
  ● Loan program income increased 70.2% to approximately $869,000, compared with approximately $511,000 in the prior-year period.
  ● Average client deposit balances increased 3.8% to $112 million, compared with approximately $108 million for the three months ended September 30, 2025.
  ● Trailing 14-day average client deposits increased 7.4% to $119.3 million as of September 30, 2026, compared with $111.1 million in the prior-year period.
  ● Average account balance increased 5.6% to approximately $147,000, compared with approximately $139,000 in the prior-year period.
  ● Total operating expenses decreased 3.2% to $2.95 million, compared with $3.05 million in the prior-year period.
  ● Compensation and employee benefits expense decreased 10.6% to $1.52 million, compared with $1.70 million for the three months ended September 30, 2025.
  ● Operating loss narrowed 17.7% to $1 million, compared with $1.22 million in the third quarter of 2025.
  ● Net loss was approximately $979,000, or $0.95 per basic and diluted share, compared with net income of approximately $180,000, or $0.74 per basic share and $0.69 per diluted share, in the prior-year period.
  ● Cash and cash equivalents totaled $4.4 million as of September 30, 2026.

 

 
 

 

Operating Performance

 

Loan program income increased approximately $359,000, or 70.2%, to approximately $869,000 in the third quarter, compared with approximately $511,000 in the prior-year period.

 

The increase was primarily attributable to Safe Harbor’s second amended commercial alliance agreement with Partner Colorado Credit Union, effective October 1, 2025. The agreement increased Safe Harbor’s share of applicable loan program income from approximately 35% to up to 65%, thereby improving the revenue contribution from its lending services despite lower average outstanding loan balances.

 

For the first nine months of 2026, loan program income increased 58.6% to $2.55 million from $1.61 million in the prior-year period. The increase primarily reflected the revised revenue-sharing arrangement rather than growth in underlying loan volume.

 

Safe Harbor’s deposit base continued to expand during the quarter. Average client deposit balances increased approximately $4.0 million year over year to $112.0 million, compared with approximately $108.0 million in the prior-year period.

 

The trailing 14-day average deposit balance at September 30, 2026, reached $119.3 million, an increase of 7.4% from $111.1 million a year earlier.

 

The Average account balance increased 5.6% to $147,209 from $139,444 in the prior-year period, while average active accounts declined 1.7% to 761 from 774. The increase in average balances reflects a shift toward larger, higher-deposit-balance client relationships.

 

Account fee income decreased 17.1% to approximately $798,000, compared with approximately $963,000 in the prior-year period. The decline primarily reflected lower revenue from a merchant service partner and competitive pressure on account fees.

 

Investment income decreased 16.7% to approximately $284,000, compared with approximately $341,000 a year earlier, as lower prevailing interest rates more than offset growth in average investable deposit balances.

 

Operating Expenses and Profitability

 

Total operating expenses decreased approximately $97,000, or 3.2%, to $2.95 million in the third quarter of 2026, compared with $3.05 million in the prior-year period.

 

The decrease included lower compensation and employee benefits expenses and an approximate $353,000 credit benefit associated with changes in estimated credit losses under the Company’s financial indemnification obligations.

 

These benefits were partially offset by increased professional services expenses and amortization of a contract asset associated with the second amended commercial alliance agreement with Partner Colorado Credit Union.

 

Professional services expenses increased 63.3% to approximately $722,000 from $442,000 a year earlier, reflecting increased legal, accounting and other professional costs.

 

Operating loss narrowed to $1 million from $1.22 million in the third quarter of 2025.

 

Safe Harbor reported a net loss of approximately $979,000, compared with net income of approximately $180,000 in the prior-year quarter. The year-over-year comparison was significantly affected by a $3.34 million gain on debt extinguishment recorded during the third quarter of 2025.

 

For the nine months ended September 30, 2026, Safe Harbor reported total revenue of $5.86 million, an increase of 4.5% from $5.61 million in the comparable 2025 period. Operating loss for the nine-month period narrowed to $3.79 million, compared with $4.18 million a year earlier.

 

 
 

 

Strategic and Business Developments

 

Safe Harbor remains focused on strengthening its core financial services platform, supporting existing client relationships and positioning its institutional banking capabilities to serve a broader range of financial institutions.

 

During the third quarter, the Company continued operating its established banking and lending platform, supported by higher average client deposit balances and increased loan program income. These results reflect the continued contribution of Safe Harbor’s financial institution relationships and specialized experience serving regulated cannabis businesses.

 

The Safe Harbor Institutional Infrastructure-as-a-Service model is an important component of the Company’s longer-term strategy. The model is designed to provide banks and credit unions with operational infrastructure, compliance support and program administration capabilities to help establish and manage cannabis banking programs.

 

During the quarter ended September 30, 2026, Safe Harbor Institutional was recognized as Top Business Solutions Company at the 2026 PBC Cannabis Banking Conference, highlighting its specialized banking infrastructure and compliance capabilities serving the regulated cannabis industry. The recognition further supports the Company’s efforts to raise awareness of its institutional offering among banks and credit unions.

 

Following the end of the quarter, Safe Harbor Institutional joined the American Bankers Association (“ABA”) Partner Network, thereby expanding its opportunities to engage with U.S. banking institutions. Through the network, the Company aims to introduce its specialized cannabis banking infrastructure and compliance capabilities to a broader audience of banking executives and decision-makers.

 

These initiatives support Safe Harbor’s strategy to strengthen its institutional presence, build relationships across the banking industry and identify opportunities to expand its financial services platform. Participation in the ABA Partner Network does not constitute an endorsement of Safe Harbor’s products or services by the ABA.

 

Management remains focused on supporting existing clients and financial institution partners, maintaining operational continuity and preserving the value of its established cannabis financial services business while addressing capital structure and liquidity requirements.

 

Balance Sheet and Liquidity

 

As of September 30, 2026, Safe Harbor reported cash and cash equivalents of $4.40 million, compared with $6.78 million as of December 31, 2025.

 

Total assets were $13.09 million as of September 30, 2026, compared with $17.21 million at year-end 2025.

 

Net cash used in operating activities totaled $4.05 million for the nine months ended September 30, 2026, compared with $2.35 million in the prior-year period.

 

The Company had no secured debt as of September 30, 2026.

 

Safe Harbor continues to manage liquidity through cash flow monitoring, expense management and evaluation of available financing and strategic alternatives.

 

The Company does not intend to draw on its existing equity line of credit while the term sheet with Opifex Media Inc. (“Opifex”) remains in effect, which will continue to limit an available source of financing.

 

The Company’s unaudited financial statements include a going concern disclosure resulting from recurring operating losses, negative operating cash flows and uncertainties related to its capital structure, litigation and other obligations. Management’s plans have not alleviated substantial doubt about the Company’s ability to continue as a going concern.

 

 
 

 

Subsequent Developments

 

Proposed Business Combination

 

On October 23, 2026, Safe Harbor entered into a nonbinding term sheet with Opifex, a Beverly Hills, California-based media holding company focused on the creator economy, regarding a proposed business combination.

 

The proposed transaction is intended to create a diversified public holding company with two distinct operating businesses. Opifex would contribute its creator-economy platform, while Safe Harbor would continue operating its established cannabis financial services business and serving its existing clients and financial institution partners.

 

As currently contemplated, Opifex security holders would own approximately 85% of the combined company’s fully diluted shares immediately after closing. Existing Safe Harbor stakeholders, including common stockholders, holders of Series B preferred stock on an as-converted basis, warrant holders and other equity award holders, would collectively own approximately 15% of the combined company. However, the Safe Harbor allocation described above may be adjusted within a range of 12.5% to 17.5% to reflect Safe Harbor’s valuation at closing, as supported by an independent fairness opinion.

 

The proposed transaction is intended to support Safe Harbor’s efforts to maintain its Nasdaq listing and provide an additional business platform for the combined company.

 

The transaction remains subject to, among other things, the negotiation of a definitive agreement, satisfactory due diligence findings by both parties, the required consents and agreements with holders of the Series B securities, the completion of Opifex’s audited financial statements, an independent valuation and fairness opinion, Safe Harbor stockholder approval, Nasdaq approval, completion of any required financing and other customary conditions.

 

Safe Harbor continues to evaluate potential arrangements involving its Series B securities in connection with the proposed transaction.

 

There can be no assurance that definitive agreements will be executed, required approvals will be obtained or the proposed transaction will be completed on the terms described above or at all.

 

Nasdaq Listing Compliance

 

On October 20, 2026, Nasdaq granted Safe Harbor an additional 180-day period, through April 19, 2027, to regain compliance with the $1 minimum bid price requirement.

 

The Company’s continued listing remains subject to applicable Nasdaq requirements, including provisions that may result in an earlier delisting determination if its common stock fails to maintain specified minimum price thresholds. Safe Harbor continues to evaluate available alternatives to address its listing requirements, including measures contemplated in connection with its proposed transaction with Opifex.

 

There can be no assurance that the Company will regain compliance or maintain its Nasdaq listing.

 

Management Priorities

 

Safe Harbor remains focused on maintaining its existing financial services operations and supporting customers and financial institution partners while evaluating alternatives to address its capital structure and public listing challenges.

 

Management’s near-term priorities include supporting client deposits, maintaining banking and lending relationships, evaluating institutional banking opportunities, managing expenses and liquidity, and pursuing strategic alternatives intended to preserve the value of the operating business.

 

“We remain committed to the clients and financial institution partners who rely on our platform,” Mr. Mendez said. “Our focus is on maintaining operational continuity, protecting the capabilities we have built and evaluating opportunities that may provide a more sustainable foundation for the business and its stakeholders.”

 

 
 

 

Third Quarter and Year-to-Date Financial Summary

 

Unaudited. Dollar amounts in thousands, except per-share data.

 

Financial metric  Q3 2026   Q3 2025 
Revenue  $1,952   $1,834 
Operating expenses  $2,954   $3,051 
Operating loss  $(1,002)  $(1,217)
Net (loss) income  $(979)  $180 
Basic (loss) income per share  $(0.95)  $0.74 
Diluted (loss) income per share  $(0.95)  $0.69 

 

Financial metric  Nine months 2026   Nine months 2025 
Revenue  $5,862   $5,611 
Operating expenses  $9,654   $9,791 
Operating loss  $(3,792)  $(4,180)
Net loss  $(4,272)  $(1,578)
Net loss attributable to common stockholders  $(5,341)  $(1,578)
Basic and diluted loss per share  $(8.08)  $(6.67)

 

Per-share figures reflect the 1-for-12 reverse stock split effective September 30, 2026.

 

About Safe Harbor

 

Safe Harbor is a cannabis-exclusive financial platform delivering smarter banking, lending, payments and business services, and institutional solutions tailored to how the cannabis industry actually operates. As one of the original pioneers of compliant financial operations support and cannabis banking consulting in the U.S., Safe Harbor has assisted in the processing of more than $38.7 billion in cannabis-related depository funds across 41 states and territories since inception. Through its proprietary technology, platform and network of regulated financial institution partners, Safe Harbor empowers cannabis operators to gain clarity, control and confidence in their financial operations. From daily banking and compliance infrastructure to long-term growth, Safe Harbor provides real solutions and personal support, built exclusively for cannabis. Safe Harbor is a financial technology company, not a bank and not a lender. Banking services are provided by our partner financial institutions. Credit decisions are made by third-party financing partners, not Safe Harbor. For more information, visit shfinancial.org.

 

Solicitation Material

 

This communication may be deemed to be solicitation material in connection with the proposals to be submitted to Safe Harbor’s stockholders at a meeting of stockholders seeking approval of certain matters in connection with the proposed transaction (the “Stockholder Meeting”). In connection with the proposals, Safe Harbor may file with the Securities and Exchange Commission (the “SEC”) a registration statement on Form S-4 (the “Registration Statement”), which will include a proxy statement of Safe Harbor and a prospectus (the “Proxy Statement/Prospectus”). After the Registration Statement is declared effective, Safe Harbor will mail the definitive Proxy Statement/Prospectus to its stockholders. INVESTORS AND SECURITY HOLDERS OF SAFE HARBOR ARE URGED TO READ THE REGISTRATION STATEMENT, THE PROXY STATEMENT/PROSPECTUS AND ALL OTHER RELEVANT DOCUMENTS FILED WITH THE SEC, AND ANY AMENDMENTS OR SUPPLEMENTS THERETO, CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT SAFE HARBOR, OPIFEX, THE PROPOSED TRANSACTION AND THE PROPOSALS. Investors and security holders may obtain free copies of the Registration Statement, the Proxy Statement/Prospectus and other documents that Safe Harbor files with the SEC, when available, at the SEC’s website (www.sec.gov) or from Safe Harbor by accessing information included on Safe Harbor’s website (ir.shfinancial.org), which is not incorporated by reference herein.

 

 
 

 

Participation in the Solicitation

 

Safe Harbor, Opifex and their respective directors and certain of their respective executive officers may be deemed participants in the solicitation of proxies from Safe Harbor’s stockholders in connection with the proposed transaction. Information about Safe Harbor’s directors and executive officers, including their ownership of Safe Harbor securities, appears in Safe Harbor’s proxy statement for its 2026 annual meeting of stockholders, filed with the SEC on May 8, 2026 (under the captions “Security Ownership of Certain Beneficial Owners and Management” and “Compensation Discussion and Analysis”), and in its Annual Report on Form 10-K filed with the SEC on April 15, 2026. Changes in their holdings since those dates have been or will be reflected in Forms 3, 4, or 5 filed with the SEC. Information about Opifex’s directors and executive officers, and additional information about all participants and a description of their direct and indirect interests, by security holdings or otherwise, will be included in the Proxy Statement/Prospectus and other relevant materials filed with the SEC when they become available. These documents can be obtained free of charge as described above.

 

No Offer or Solicitation

 

This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

 

Cautionary Statement Regarding Forward-Looking Statements

 

Certain information contained in this press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included herein may constitute forward-looking statements and are not guarantees of future performance or results and involve a number of risks and uncertainties. Forward-looking statements may include, but are not limited to, statements with respect to trends in the cannabis industry, including proposed changes in U.S. and state laws, rules, regulations and guidance relating to Safe Harbor’s services; Safe Harbor’s growth prospects and Safe Harbor’s market size; Safe Harbor’s projected financial and operational performance, including relative to its competitors and historical performance; success or viability of new product and service offerings Safe Harbor may introduce in the future; the impact of volatility in the capital markets, which may adversely affect the price of Safe Harbor’s securities; the outcome of any legal proceedings that have been or may be brought by or against Safe Harbor; the execution of definitive agreements for the proposed transaction or the closing thereof; the Stockholder Meeting; and other statements regarding Safe Harbor’s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “outlook,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would,” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including, without limitation: the occurrence of any event, change or other circumstances that could give rise to the termination of the term sheet or prevent the execution of any definitive agreements with respect to the proposed transaction; the inability to complete the proposed transaction due to the failure to obtain the required stockholder approvals or any other required agreements, approvals or consents, including the consent of the holders of the Series B preferred stock required under the Series B transaction documents; the inability to obtain the required financing to complete the proposed transaction or to satisfy other conditions to closing; changes to the proposed structure of the proposed transaction that may be required or appropriate as a result of applicable laws or regulations or as a condition to obtaining any required approval of the proposed transaction; Safe Harbor’s ability to regain compliance with the Nasdaq minimum bid price requirement by April 19, 2027; dilution to the Company’s existing stockholders; Opifex’s ability to complete its pending acquisitions and deliver audited financial statements; and other risks and uncertainties described from time to time in Safe Harbor’s filings with the SEC. Safe Harbor undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release.

 

Safe Harbor Investor Relations Contact:

 

ir@SHFinancial.org

 

Safe Harbor Media Relations Contact:

 

safeharbor@kcsa.com

 

 

 

 

Exhibit 99.2

 

Safe Harbor CEO Issues Letter to Shareholders Addressing Capital Structure, Nasdaq Listing and Proposed Opifex Transaction

 

Letter accompanies the release of the Company’s third-quarter financial results

 

GOLDEN, Colo., Nov. 9, 2026 — SHF Holdings, Inc., doing business as Safe Harbor (“Safe Harbor” or the “Company”) (Nasdaq: SHFS), a fintech platform serving the banking, lending and financial services needs of the regulated cannabis and hemp industries, today released a letter to shareholders from Terrance Mendez, the Company’s Chief Executive Officer, Chief Financial Officer and a member of its Board of Directors. The letter accompanies the Company’s release of its third-quarter financial results.

 

Dear Fellow Shareholders,

 

The last several weeks have been difficult for Safe Harbor’s stockholders, and I want to address that directly. Our share price has declined sharply since our reverse stock split on September 30, 2026, and recent conversions of our Series B Convertible Preferred Stock have substantially diluted our common stockholders. Shareholders have raised important questions with our investor relations team. This letter aims to answer them so that every shareholder has the same information at the same time.

 

Our core business continues to grow

 

Our operating business performed well in the third quarter. Revenue was $1.95 million, up 6.5% from $1.83 million a year ago. Loan program income rose 70.2% to approximately $869,000, reflecting our larger share of loan program income under the Second Amended Commercial Alliance Agreement with Partner Colorado Credit Union (“PCCU”), which increased from approximately 35% up to 65% effective October 1, 2025. For the first nine months of 2026, revenue was $5.86 million, up 4.5% compared to the prior year.

 

For the three months ended September 30, 2026, our client deposits also grew. Average client deposit balances rose 3.8% to $112.0 million, and our trailing 14-day average deposit balance at quarter-end reached $119.3 million, up 7.4% from a year earlier. Total operating expenses for the quarter declined 3.2% to $2.95 million compared to the three months ended September 30, 2025, and our operating loss also narrowed 17.7% to approximately $1.0 million.

 

I also want to be clear about our challenges. We reported a net loss of approximately $979,000 for the quarter. Account fee income declined 17.1% and professional services costs rose 63.3% compared with the third quarter of 2025, reflecting increased legal, accounting and other professional costs. We continue to operate at a loss, our liquidity is limited, and our financial statements include a going concern disclosure.

 

What happened to our share count

 

To understand the dilution, it helps to revisit how the issuance of the Series B securities came about. In May 2025, we were reporting that the Company’s liabilities exceed its assets and it would not have enough cash to complete the year without a recapitalization. In September 2025, we completed a recapitalization that, as described in our 2025 Annual Report on Form 10-K, cancelled our approximately $10.7 million PCCU note, terminated our forward purchase agreement and brought in new capital in exchange for Series B Convertible Preferred Stock and Series B Warrants. It also established our equity line of credit. That transaction stabilized our balance sheet at a critical time. However, the Series B terms included price adjustment provisions that have since worked against common stockholders.

 

On September 30, 2026, the Company effected a 1-for-12 reverse stock split of its Common Stock pursuant to a Certificate of Amendment to its Second Amended and Restated Certificate of Incorporation filed with the Secretary of State of the State of Delaware, which became effective on September 30, 2026. The 2026 Reverse Stock Split was approved by the Company’s stockholders on November 6, 2025, and the 1-for-12 ratio was approved by the board of directors of the Company (the “Board” or the “Board of Directors”) on September 16, 2026.

 

The September 30, 2026 reverse stock split triggered a provision of the Series B documents that resulted in a reset of the conversion price of the Series B Convertible Preferred Stock to the average of the five lowest daily volume-weighted average prices in the 15 trading days after the split. On October 22, 2026, the conversion price reset from $18.6336 to $0.1210 per share. The exercise price of the Series B Warrants did not change and remains $18.6336.

 

 
 

 

From October 22 through November 6, 2026, holders of the Series B Convertible Preferred Stock converted 19,529 shares into 131,219,818 shares of common stock. As a result, our common shares outstanding increased from 1,028,702 on September 30 to 132,248,520 on November 6. As of November 6, 2026, 7,605 shares of Series B Convertible Preferred Stock remained outstanding, which are currently convertible into a maximum of approximately 62.9 million additional shares.

 

The Series B also carries other obligations that we have described in prior filings, and we continue to evaluate potential arrangements involving the Series B securities, including in connection with the proposed transaction with Opifex Media, Inc. (“Opifex”). If we reach any agreement, we intend to disclose it promptly through our SEC filings.

 

Our use of the equity line

 

We raised $1.1 million under our equity line of credit during the first nine months of 2026. Under its terms, 25% of the proceeds of each draw must be used to redeem Series B Convertible Preferred Stock, and our ability to draw is limited when our stock trades below $1.00. We do not intend to draw on the equity line while the Opifex term sheet remains in effect. However, we continue to manage spending against a 52-week rolling cash forecast and have identified cost reductions within our control that we would implement if necessary.

 

Our plan for Nasdaq compliance

 

We effected the September 30 reverse split to address Nasdaq’s $1.00 minimum bid price requirement. Our stock has largely traded below $1.00 since the split, and we did not regain compliance by the end of our initial compliance period on October 19. On October 20, 2026, Nasdaq granted us a second 180-day compliance period, through April 19, 2027. To regain compliance, our stock must close at or above $1.00 for at least 10 consecutive business days before that date.

 

We intend to evaluate all available options, including a further reverse stock split, which would require stockholder approval. In connection with the proposed Opifex transaction, we may seek stockholder approval of a reverse split to the extent needed to meet the bid price requirement.

 

Under Nasdaq rules, if our common stock has a closing bid price of $0.10 or less for ten consecutive business days, Nasdaq will issue a delisting determination regardless of any remaining compliance period, and our stock would be suspended from trading on Nasdaq while any appeal is pending. Our common stock has recently closed below $0.10 on eight consecutive business days, and, if that continues, our stock could be suspended and delisted from Nasdaq before April 19, 2027.

 

If our common stock is suspended or delisted, we expect it would be quoted on an over-the-counter market. We cannot assure you that it would qualify for the OTCQB Venture Market, which has its own eligibility standards, including a minimum bid price, rather than OTC Pink. Over-the-counter quotation generally offers less liquidity and visibility than a national exchange. A suspension or delisting could also constitute a Triggering Event under the Series B Certificate of Designations and could affect the proposed Opifex transaction, which requires Nasdaq approval of our continued or initial listing.

 

Separately, our stockholders’ equity as of September 30, 2026, was $5.2 million, exceeding Nasdaq’s $2.5 million minimum stockholders’ equity requirement by $2.7 million. However, meeting this requirement does not resolve our minimum bid price deficiency.

 

Maintaining our listing is a priority, and we are working diligently toward compliance. There can be no assurance that we will succeed.

 

 
 

 

The proposed transaction with Opifex Media

 

On October 23, 2026, we signed a non-binding term sheet with Opifex Media, Inc., a Beverly Hills, California-based media holding company focused on the creator economy. Under the proposed terms, a wholly owned subsidiary of SHFS would merge with and into Opifex, and Opifex security holders would receive newly issued SHFS common stock. The transaction is expected to be accounted for as a reverse acquisition, with Opifex as the accounting acquirer.

 

Here is what the proposed terms would mean for existing shareholders:

 

  ● Ownership. Opifex security holders would own approximately 85% of the combined company on a fully diluted basis. All legacy SHF Holdings Inc. shareholders would own approximately 15%, subject to adjustment between 12.5% and 17.5% based on a fairness opinion, and gain exposure to a new business.
  ● The combined company. The combined company would be expected to have a different business focus, name, board of directors and management.
  ●

Litigation. Under the term sheet, Opifex would acquire the Company including the Abaca litigation, and its resolution would not be a condition to closing.

  ● Listing. The combined company could be required to meet Nasdaq’s initial listing requirements, which are more stringent than the continued listing requirements.
  ● Stockholder vote. Completing the transaction would require stockholder approval, including any reverse stock split and increase in authorized shares. Stockholders would receive a proxy statement and other materials describing the transaction before any vote.

 

The term sheet is non-binding except for certain specified provisions. Completing the transaction depends on, among other things, definitive agreements, due diligence, approval by certain holders of Series B Convertible Preferred Stock, the conversion of the Series B Securities to common stock, Opifex’s audited financial statements, a fairness opinion, stockholder approval, an equity financing and Nasdaq approval. There is no assurance that definitive agreements will be signed or that the transaction will be completed on these terms before April 19, 2027, or at all. We will update you through our SEC filings as the negotiations progress.

 

Other matters you may be asking about

 

Abaca litigation. The trial concerning damages and the remaining claims in our dispute with the former owners of Abaca was held on August 10 and 11, 2026. The court has not issued a ruling yet, and we cannot predict when it will or what the outcome will be. We estimate the range of reasonably possible loss at $0 to $7.8 million, plus interest. An adverse ruling at or near the upper end of that range would exceed our available liquidity, and the $3.0 million we previously deposited in the court’s registry is not available to fund operations.

 

PCCU. On October 21, 2026, PCCU sold all of its Series B Convertible Preferred Stock to another Series B holder in a private transaction to which the Company was not a party. As a result, we no longer consider PCCU a related party. PCCU remains our largest customer and most important financial institution partner. It also serves as the depository for substantially all of our cash.

 

How we will communicate from here

 

You deserve clear and consistent information. We will report developments on the Opifex transaction, any arrangement involving the Series B securities, our Nasdaq listing and the Abaca ruling in filings with the SEC. Questions may be directed to ir@SHFinancial.org; however, we cannot share nonpublic information with any individual investor.

 

Looking ahead

 

Through a period of significant challenges, our team has stayed focused on serving our clients and financial institution partners, and our core business has continued to grow. Our priorities are clear: preserving liquidity, maintaining our Nasdaq listing, addressing our capital structure, and pursuing a strategic path that preserves value for shareholders. Important work remains, and outcomes are not guaranteed. I will continue to report to you openly as these efforts advance.

 

Thank you for your patience and your continued support.

 

Sincerely,

 

Terrance E. Mendez

Chief Executive Officer, Chief Financial Officer, and Director of SHF Holdings, Inc.

 

 
 

 

About Safe Harbor

 

Safe Harbor is a cannabis-exclusive financial platform delivering smarter banking, lending, payments and business services, and institutional solutions tailored to how the cannabis industry actually operates. As one of the original pioneers of compliant financial operations support and cannabis banking consulting in the U.S., Safe Harbor has assisted in the processing of more than $38.7 billion in cannabis-related depository funds across 41 states and territories since inception. Through its proprietary technology, platform and network of regulated financial institution partners, Safe Harbor empowers cannabis operators to gain clarity, control and confidence in their financial operations. Safe Harbor is a financial technology company, not a bank and not a lender. Banking services are provided by our partner financial institutions. Credit decisions are made by third-party financing partners, not Safe Harbor. For more information, visit shfinancial.org.

 

Solicitation Material

 

This communication may be deemed to be solicitation material in connection with the proposals to be submitted to Safe Harbor’s stockholders at a meeting of stockholders seeking approval of certain matters in connection with the proposed transaction. In connection with the proposals, Safe Harbor may file with the Securities and Exchange Commission (the “SEC”) a registration statement on Form S-4 (the “Registration Statement”), which will include a proxy statement of Safe Harbor and a prospectus (the “Proxy Statement/Prospectus”). After the Registration Statement is declared effective, Safe Harbor will mail the definitive Proxy Statement/Prospectus to its stockholders. INVESTORS AND SECURITY HOLDERS OF SAFE HARBOR ARE URGED TO READ THE REGISTRATION STATEMENT, THE PROXY STATEMENT/PROSPECTUS AND ALL OTHER RELEVANT DOCUMENTS FILED WITH THE SEC, AND ANY AMENDMENTS OR SUPPLEMENTS THERETO, CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT SAFE HARBOR, OPIFEX, THE PROPOSED TRANSACTION AND THE PROPOSALS. Investors and security holders may obtain free copies of the Registration Statement, the Proxy Statement/Prospectus and other documents that Safe Harbor files with the SEC, when available, at the SEC’s website (www.sec.gov) or from Safe Harbor by accessing information included on Safe Harbor’s website (ir.shfinancial.org), which is not incorporated by reference herein.

 

Participation in the Solicitation

 

Safe Harbor, Opifex and their respective directors and certain of their respective executive officers may be deemed participants in the solicitation of proxies from Safe Harbor’s stockholders in connection with the proposed transaction. Information about Safe Harbor’s directors and executive officers, including their ownership of Safe Harbor securities, appears in Safe Harbor’s proxy statement for its 2026 annual meeting of stockholders, filed with the SEC on May 8, 2026 (under the captions “Security Ownership of Certain Beneficial Owners and Management” and “Compensation Discussion and Analysis”), and in its Annual Report on Form 10-K filed with the SEC on April 15, 2026. Changes in their holdings since those dates have been or will be reflected in Forms 3, 4, or 5 filed with the SEC. Information about Opifex’s directors and executive officers, and additional information about all participants and a description of their direct and indirect interests, by security holdings or otherwise, will be included in the Proxy Statement/Prospectus and other relevant materials filed with the SEC when they become available. These documents can be obtained free of charge as described above.

 

 
 

 

No Offer or Solicitation

 

This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

 

Cautionary Statement Regarding Forward-Looking Statements

 

This letter contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements about the Proposed Transaction with Opifex, the Series B Convertible Preferred Stock and Series B Warrants, our Nasdaq listing, the Abaca litigation, our liquidity and our business. Words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “should,” “would” and similar expressions may identify forward-looking statements. These statements are based on current expectations and are subject to risks and uncertainties that could cause actual results to differ materially, including: the termination of the term sheet or failure to execute definitive agreements for the Proposed Transaction; failure to obtain required stockholder, Nasdaq or other approvals or consents, including any required arrangements with holders of the Series B securities; failure to obtain required financing or satisfy other closing conditions; further conversions of the Series B Convertible Preferred Stock and resulting dilution; our ability to meet registration obligations and avoid Triggering Events under the Series B documents; our ability to regain compliance with the Nasdaq minimum bid price requirement by April 19, 2027 and to maintain compliance with other listing requirements; the suspension or delisting of our common stock from Nasdaq, including under Nasdaq’s rule requiring a delisting determination if our common stock has a closing bid price of $0.10 or less for ten consecutive business days, and the effect of any suspension or delisting on the liquidity and market price of our common stock, on the Series B securities and on the Proposed Transaction; the outcome and timing of the Abaca litigation; our liquidity and ability to continue as a going concern; our dependence on PCCU; Opifex’s ability to complete its pending acquisitions and deliver audited financial statements; and the other risks described in our Annual Report on Form 10-K for 2025 and our Quarterly Reports on Form 10-Q, including for the quarter ended September 30, 2026. Forward-looking statements speak only as of the date of this letter, and we undertake no obligation to update them except as required by law.

 

Safe Harbor Investor Relations Contact

 

ir@SHFinancial.org

 

Safe Harbor Media Relations Contact

 

safeharbor@kcsa.com

 

 

 

Filing Exhibits & Attachments

6 documents

Keep reading